SMG
Scotts Miracle-Gro CoPrice & Indicators
TL;DR.
AI-generated from the earnings call and 8-K · may contain errors · not investment advice
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders NeutralIllustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from its earnings releases, calls, and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| Net leverage | 3.71 | Q2 FY2026 | — |
|
|
|||
| Non-GAAP adjusted EBITDA non-GAAP | $437.4M | Q2 FY2026 | — |
| debt-to-EBITDA leverage | 3.71 | Q2 FY2026 call | — |
| new product SKUs introduced | 83 | FY2026 year-to-date call | — |
| Non-GAAP adjusted gross margin rate non-GAAP | 25.4% | Q1 FY2026 | — |
| U.S. Consumer net sales | $328.5M | Q1 FY2026 | — |
Figures exactly as the company stated them · click a metric with a to chart its history · period links open the stating document · "call" marks figures stated on the earnings call, "filing" figures stated in the 10-K/10-Q · YoY needs the prior-year figure on file
Versus peers
Agricultural Inputs — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
SMG
this stock
Scotts Miracle-Gro Co
|
$3.81B | +13.3% | +6.2% | 35.6 | 9.8% |
|
CTVA
Corteva, Inc.
|
$57.30B | +28.1% | +2.9% | 49.8 | 2.8% |
|
NTR
Nutrien Ltd.
|
$31.41B | +6.8% | — | — | 2.1% |
|
CF
CF Industries Holdings, Inc.
|
$17.96B | +52.0% | +19.3% | 10.5 | 6.7% |
|
YARIY
Yara International ASA
|
$11.62B | +11.8% | — | — | 0.0% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionPerformance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| SMG | -4.9% | +10.3% | +3.1% | -3.9% | +13.3% |
| SPY | +1.4% | +4.1% | +9.1% | +1.1% | +10.7% |
| vs SPY | -6.3% | +6.2% | -6.0% | -5.0% | +2.6% |
Capital returns
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.